Is the patient on immunotherapy?
Warning
Is the patient on immunotherapy? (such as pembrolizumab, nivolumab, ipilimumab, atezolizumab, avelumab, durvalumab, cemiplimab)?
Immune-related gastrointestinal toxicity1.
Symptoms: diarrhoea, abdominal pain, PR bleeding, fever, vomiting.
1. Abridged from: NHS Lothian Immunotherapy toxicity management guidelines v7.0. S Clive & C Barrie. Last reviewed: 22.11.2021.